UPDATE : Monday, February 17, 2020
상단여백
Regulator raids cell therapy makers too often to little avail by Jeong Sae-im 2019-10-02 11:23
Will parliamentary audit uncover why Invossa was mislabeled? by Jeong Sae-im 2019-10-01 15:45
Ranitidine recall taking heavy toll on pharmaceuticals by Jeong Sae-im 2019-09-30 15:16
Regulator explained why it banned stomach medicine ranitidine altogether by Jeong Sae-im 2019-09-27 15:02
‘Samsung BioLogics destroyed evidence to hide accounting fraud for months’ by Jeong Sae-im 2019-09-26 15:24
라인
Helixmith blames hospital for absurd drug mix-up by Jeong Sae-im 2019-09-25 13:42
Court rejects Kolon’s appeal over Invossa license revocation by Jeong Sae-im 2019-09-25 11:18
FDA recommends Kolon to remanufacture Invossa’s second fluid by Jeong Sae-im 2019-09-23 15:32
Drug firms uncertain about pricing of quadrivalent flu vaccines by Jeong Sae-im 2019-09-23 14:52
‘Galderma Korea ran background checks on unionized workers’ by Jeong Sae-im 2019-09-19 15:18
라인
Regulator delays decision on delisting Kolon TissueGene by Jeong Sae-im 2019-09-18 14:27
Biotech startups seek IPO via ‘growth potential exception’ policy by Jeong Sae-im 2019-09-17 11:26
Chong Kun Dang wins patent suit against Novartis over immunosuppressant by Jeong Sae-im 2019-09-11 15:16
Daewoong to test botulinum toxin Nabota for hair loss by Jeong Sae-im 2019-09-11 13:56
Novartis withdraws suit against Ahngook’s generic drug by Jeong Sae-im 2019-09-10 15:38
라인
Invossa victims furious at government, Kolon for ‘doing nothing’ by Jeong Sae-im 2019-09-09 15:47
Nobel laureate Honjo anticipates best combo in immunotherapies by Jeong Sae-im 2019-09-06 16:29
Yuhan to expand biz scope to central nervous system disease by Jeong Sae-im 2019-09-06 14:56
SK goes global by developing new drugs, conducting CDMO biz by Jeong Sae-im 2019-09-03 14:58
Hanmi, Daewoong among 20 innovative top-tier drugmakers in Asia Pacific by Jeong Sae-im 2019-09-02 17:33
여백
여백
여백
Back to Top